Issued Patents All Time
Showing 26–50 of 70 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11220490 | Ureas having androgen receptor degradation activity and uses thereof | Jie Fan, Wei He, Ke Liu | 2022-01-11 |
| 11191741 | Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide | Andrew P. Crew, Lawrence B. Snyder, Jing Wang, Michael Berlin | 2021-12-07 |
| 11104666 | Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders | Andrew P. Crew, Hanqing Dong, Jing Wang, Keith R. Hornberger | 2021-08-31 |
| 10946017 | Tank-binding kinase-1 PROTACs and associated methods of use | Andrew P. Crew, Jing Wang, Hanqing Dong | 2021-03-16 |
| 10899742 | Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders | Andrew P. Crew, Hanqing Dong, Jing Wang | 2021-01-26 |
| 10865202 | Indole derivatives as estrogen receptor degraders | Andrew P. Crew, Hanqing Dong, Jing Wang | 2020-12-15 |
| 10836749 | Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereof | Jie Fan, Wei He, Ke Liu | 2020-11-17 |
| 10800770 | Chroman derivatives having estrogen receptor degradation activity and uses thereof | Jie Fan, Wei He, Ke Liu | 2020-10-13 |
| 10772962 | Compounds and methods for the targeted degradation of bromodomain-containing proteins | Hanqing Dong, Jing Wang, Michael Berlin, Andrew P. Crew, Craig M. Crews | 2020-09-15 |
| 10730870 | Compounds and methods for the enhanced degradation of targeted proteins | Andrew P. Crew, Craig M. Crews, Xin Chen, Hanqing Dong, Caterina Ferraro +6 more | 2020-08-04 |
| 10723717 | Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides | Andrew P. Crew, Keith R. Hornberger, Jing Wang, Hanqing Dong, Craig M. Crews +1 more | 2020-07-28 |
| 10647698 | Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders | Andrew P. Crew, Hanqing Dong, Jing Wang | 2020-05-12 |
| 10604506 | Modulators of estrogen receptor proteolysis and associated methods of use | Andrew P. Crew, Keith R. Hornberger, Hanqing Dong, Jing Wang, Craig M. Crews | 2020-03-31 |
| 10174037 | Dihydropyrazolopyrimidinone compounds as PDE2 inhibitors | Dong-Ming Shen, Michael P. Dwyer, Christopher Joseph Sinz, Deping Wang, Shawn J. Stachel +6 more | 2019-01-08 |
| 10160762 | 6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors | Dong-Ming Shen, Michael P. Dwyer, Christopher Joseph Sinz, Deping Wang, Shawn J. Stachel +11 more | 2018-12-25 |
| 9988397 | ERK inhibitors | Phieng Siliphaivanh, David L. Sloman, David J. Witter, Umar Faruk Mansoor, Joseph A. Kozlowski +5 more | 2018-06-05 |
| 9815796 | Pyrimidone carboxamide compounds as PDE2 inhibitors | Dong-Ming Shen, Melissa Egbertson, Richard Berger, Xiaoxia Qian, Bart Harper +9 more | 2017-11-14 |
| 9580411 | Substituted sulfonamide compounds | Christine E. Brotherton-Pleiss, Huifen Chen, Shaoqing Chen, Zhi Chen, Shawn David Erickson +8 more | 2017-02-28 |
| 9394304 | Imidazopyridine derivatives | Stephan Bachmann, Shawn David Erickson, Dramane I. Laine | 2016-07-19 |
| 9359337 | Acetamide derivatives | Christine E. Brotherton-Pleiss, Zhi Chen, Shawn David Erickson | 2016-06-07 |
| RE46024 | Thyroid hormone analogs | Nancy-Ellen Haynes, Denis John Kertesz, Sherrie Lynn Pietranico-Cole, Nathan Robert Scott, Sung-Sau So +2 more | 2016-06-07 |
| 9353096 | Substituted phenylcarbamate compounds | Christine E. Brotherton-Pleiss, Zhi Chen, Shawn David Erickson, Kyungjin Kim, Hongju Li +3 more | 2016-05-31 |
| 9321738 | N-alkyltriazole compounds as LPAR antagonists | Stephen Deems Gabriel, Matthew Hamilton, Matthew C. Lucas, Achyutharao Sidduri | 2016-04-26 |
| 9169215 | LPAR—substituted cyanopyrazole compounds | David Budd, Ryan Craig Schoenfeld, Achyutharao Sidduri | 2015-10-27 |
| 8729078 | Inhibitors of bruton's tyrosine kinase | Roland Joseph Billedeau, Rama K. Kondru, Francisco Javier Lopez-Tapia, Yan Lou, Timothy D. Owens +4 more | 2014-05-20 |